Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.

Population

Intervention or exposure

Comparison

Outcome

Any field or review title

Field or topic

Source

Review versions

75,239 questions in 5,342 reviews

current versions

No studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Question	Effect	Evidence	Status / GRADE
Testosterone as an add‐on to PDE5I vs PDE5I alone Sexual quality of life · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	2 studies · 282 participants	Low
Testosterone as an add‐on to PDE5I vs PDE5I alone Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	NR	No studies
Testosterone as an add‐on to PDE5I vs PDE5I alone Treatment withdrawal due to adverse events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	RR 1.26 [0.32, 4.91]	3 studies · 388 participants	Low
Testosterone as an add‐on to PDE5I vs PDE5I alone Prostate‐related events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	RR 6.83 [0.84, 55.37]	3 studies · 373 participants	Very low
Testosterone as an add‐on to PDE5I vs PDE5I alone Lower urinary tract symptoms · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	NR	No studies
Testosterone vs placebo Sexual quality of life · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	5 studies · 1030 participants	Moderate
Testosterone vs placebo Sexual quality of life · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	2 studies · 786 participants	Moderate
Testosterone vs placebo Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	RR 0.83 [0.21, 3.26]	10 studies · 3525 participants	Moderate
Testosterone vs placebo Treatment withdrawal due to adverse events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	RR 0.81 [0.56, 1.19]	12 studies · 2966 participants	Moderate
Testosterone vs placebo Prostate‐related events: · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	RR 1.65 [1.08, 2.51]	10 studies · 3439 participants	Moderate
Testosterone vs placebo Lower urinary tract symptoms · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	6 studies · 1488 participants	Moderate
Testosterone vs placebo Erectile function · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane	no estimate extracted	1 study · 42 participants	Very low
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB All‐cause mortality short‐term · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	Peto OR 7.22 [0.45, 115.43]	12 studies · 1390 participants	Very low
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB Serious adverse events (SAEs) start of surgery until 8 hours after surgery · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	no estimate extracted	1 study · 25 participants	Very low
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB Health‐related quality of life · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	no estimate extracted	5 studies · 440 participants	Moderate
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB Serious adverse events (SAEs) start of surgery until 8 hours after surgery · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	Peto OR 0.95 [0.59, 1.52]	21 studies · 2231 participants	Very low
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs moderate NMB Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	Peto OR 0.9 [0.56, 1.42]	16 studies · 1764 participants	Very low
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB All‐cause mortality ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	no estimate extracted	NR	No studies
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB Health‐related quality of life ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	no estimate extracted	NR	No studies
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs shallow NMB Short‐term serious adverse events (SAEs) · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	RR 1.66 [0.5, 5.57]	2 studies · 158 participants	Very low
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB All‐cause mortality start of surgery ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	no estimate extracted	NR	No studies
Summary of findings table ‐ Deep neuromuscular blockade (NMB) vs no NMB Health‐related quality of life ‐ not reported · adults undergoing intra‐ and transperitoneal laparoscopic procedures Deep neuromuscular blockade in adults undergoing an abdominal laparoscopic procedure (2024) · Cochrane	no estimate extracted	NR	No studies
Surgical thrombectomy vs pulse spray technique Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 1.05 [0.86, 1.29]	2 studies · 100 participants	Very low
Surgical thrombectomy vs mechanical thrombectomy Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.92 [0.64, 1.32]	3 studies · 404 participants	Very low
Surgical thrombectomy vs mechanical thrombectomy Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.97 [0.85, 1.1]	2 studies · 251 participants	Low
Surgical thrombectomy vs mechanical thrombectomy Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Surgical thrombectomy vs mechanical thrombectomy Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Surgical thrombectomy vs mechanical thrombectomy Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 1.98 [0.78, 5.03]	3 studies · 404 participants	Very low
Surgical thrombectomy vs mechanical thrombectomy Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.89 [0.54, 1.48]	3 studies · 404 participants	Very low
Surgical thrombectomy vs mechanical thrombectomy Death · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 1.15 [0.17, 7.99]	1 study · 153 participants	Very low
Mechanical thrombectomy vs pulse spray technique Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.96 [0.82, 1.12]	3 studies · 372 participants	Very low
Mechanical thrombectomy vs pulse spray technique Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.72 [0.41, 1.25]	3 studies · 372 participants	Very low
Mechanical thrombectomy vs pulse spray technique Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 1.04 [0.94, 1.14]	3 studies · 372 participants	Very low
Surgical thrombectomy vs pulse spray technique Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.67 [0.14, 3.17]	1 study · 20 participants	Very low
Mechanical thrombectomy vs pulse spray technique Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Mechanical thrombectomy vs pulse spray technique Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Mechanical thrombectomy vs pulse spray technique Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 1.26 [0.54, 2.92]	3 studies · 372 participants	Very low
Mechanical thrombectomy vs pulse spray technique Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.7 [0.1, 4.98]	2 studies · 252 participants	Very low
Mechanical thrombectomy vs pulse spray technique Death · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 6.56 [0.35, 124.23]	1 study · 120 participants	Very low
Mechanical thrombectomy vs continuous infusion Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.93 [0.84, 1.02]	2 studies · 118 participants	Very low
Mechanical thrombectomy vs continuous infusion Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Mechanical thrombectomy vs continuous infusion Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 1 [0.87, 1.15]	1 study · 40 participants	Very low
Mechanical thrombectomy vs continuous infusion Access dysfunction · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Mechanical thrombectomy vs continuous infusion Successful dialysis · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Surgical thrombectomy vs pulse spray technique Technical success · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Mechanical thrombectomy vs continuous infusion Major adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Mechanical thrombectomy vs continuous infusion Minor adverse events · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	RR 0.32 [0.09, 1.16]	2 studies · 118 participants	Very low
Mechanical thrombectomy vs continuous infusion Death · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Surgical thrombectomy vs continuous infusion Patency at 30 days · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies
Surgical thrombectomy vs continuous infusion Failure · thrombosed haemodialysis arteriovenous fistulas and grafts Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (2024) · Cochrane	no estimate extracted	NR	No studies